Results 101 to 110 of about 359,969 (343)

Adverse Aftereffects of Methotrexate as Chemotherapy on Cognitive Deficits in Rat Models [PDF]

, 2020
Patients with acute lymphoblastic leukemia have a high five-year survival rate thanks to methotrexate (MTX). However, cognitive side effects are reported, characterized as chemo brain.
Kang, Jubin
core   +1 more source

Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer

Advanced Science, EarlyView.
This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan, Kun Shao, Roopa Hebbandi Nanjundappa, Daniel‐Jiajun Yu, Marianne Stanford, Huile Gao, Channakeshava Sokke Umeshappa   +6 more
wiley   +1 more source

Risk of liver disease in methotrexate treated patients

World Journal of Hepatology, 2017
Methotrexate is the first line drug treatment for a number of rheumatic and non-rheumatic diseases. It is effective in controlling disease activity and preventing disease-related damage, and significantly cheaper than many alternatives. Use in rheumatoid
R. Conway, J. Carey
semanticscholar   +1 more source

Treating Rheumatoid Arthritis yesterday and today [PDF]

, 2004
Rheumatoid arthritis is a chronic, systemic inflammatory disorder that mainly affects joints. It is the most common form of inflammatory joint disease, and the second commonest joint disease, osteoarthritis being the commonest.
Mallia, Carmel
core  

Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates [PDF]

, 2008
Purpose To elucidate the role of the renal basolateral transporter, Oat3, in the disposition of methotrexate. Materials and Methods Chinese hamster ovary cells expressing mouse Oat3 were used to determine kinetics and specificity of inhibition of ...
Sweet, Douglas H., VanWert, Adam L.
core   +2 more sources

Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis

Advanced Science, EarlyView.
This manuscript presents a carrier‐free nanomedicine PCNPs@PEG‐Man with dual‐targeting for IBD. It resists harsh intestinal conditions, reduces oxidative stress, enhances drug uptake and retention, modulates inflammation, and reshapes gut microbiota, offering a safe and effective IBD therapy.
Yingjie Chen, Yuhan Gao, Kaiyuan Huo, Zhaofan Jin, Wenchao Wang, Xingjie Zan, Yanlong Liu, Limeng Zhu, Jianfeng Yang   +8 more
wiley   +1 more source

A Dual Approach with Organoid and CRISPR Screening Reveals ERCC6 as a Determinant of Cisplatin Resistance in Osteosarcoma

Advanced Science, EarlyView.
This study utilizes patient‐derived osteosarcoma organoids and CRISPR screening to identify ERCC6 and HNRNPM as key mediators of cisplatin resistance via the PI3K/AKT pathway and BAX alternative splicing. These findings provide novel insights and potential therapeutic targets for overcoming chemoresistance in osteosarcoma.
Ruiling Xu, Sai Zhu, Wenchao Zhang, Haodong Xu, Chao Tu, Honghui Wang, Lu Wang, Na He, Tang Liu, Xiaoning Guo, Xiaolei Ren, Zhihong Li   +11 more
wiley   +1 more source

Adipocytes Promote Cisplatin Resistance through Secreting A1BG and Regulating NAMPT/PARP1 Axis‐Mediated DNA Repair in Osteosarcoma

Advanced Science, EarlyView.
The proposed working model for how adipocytes participate in cisplatin resistance in osteosarcoma. The adipocytes secret A1BG and stabilize NAMPT, leading to increased NAD⁺ levels and subsequent increased PARP1‐mediated DNA repair, resulting in cisplatin resistance in osteosarcoma finally.
Yonghui Liang, Zhaohui Li, Lina Tang, Zhen Pan, Xiang Fei, Chen Tan, Aina He, Qingcheng Yang, Dongdong Cheng   +8 more
wiley   +1 more source

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

Cochrane Database of Systematic Reviews, 2016
BACKGROUND Methotrexate is considered the preferred disease-modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis, but controversy exists on the additional benefits and harms of combining methotrexate with other DMARDs ...
G. Hazlewood, C. Barnabe, G. Tomlinson, D. Marshall, D. Devoe, C. Bombardier   +5 more
semanticscholar   +1 more source

Interventions for the treatment of oral cavity and oropharyngeal cancer:chemotherapy [PDF]

, 2010
<b>Background:</b> Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally surgery followed by radiotherapy, whereas oropharyngeal
Abdel Wahab, Abele, Adelstein, Adelstein, Adelstein, Andreadis, Andres, Anonymous, Anonymous, Ansfield, Arcangeli, Aref, Attner, Bachaud, Bakowski, Bensadoun, Berger, Bernier, Bernier, Bezwoda, Biakhov, Biakhov, Bitter, Bitter, Blasio, Boidi, Bolla, Bonner, Bourhis, Bourhis, Bradley, Brigham, Brizel, Browman, Browman, Browman, Browman, Browman, Browman, Browman, Browman, Brunin, Brunin, Budach, Budach, Buentzel, Buentzel, Buntzel, Buntzel, Buntzel, Buntzel, Cachin, Calais, Calais, Calais, Calais, Calais, Calais, Caponigro, Caponigro, Cappelaere, Cappelaere, Carugati, Chassagne, Chauvergne, Chauvergne, Clavel, Clifford, Coates, Coninx, Coninx, Conway, Cooper, Corey, Corvo, Corvo, Corvo, Crispino, Cruz, Cummings, Dalley, Datta, Day, DeConti, Denis, Denis, Depondt, Dobrowsky, Dobrowsky, Domenge, Domenge, Domenge, Domenge, Ebeling, Eschwege, Eschwege, Ezra, Faggiano, Fakhry, Fanucchi, Fazekas, Fazekas, Fety, Fety, Fonseca, Forastiere, Fountzilas, Fountzilas, Fu, Fu, Fujii, Fujii, Funk, Furukawa, Gabriele, Gasparini, Gedouin, Gedouin, Gehanno, Gibson, Gladkov, Gollin, Gonzalez-Larriba, Grandi, Grau, Grau, Grau, Griem, Gupta, Gupta, Haas, Haas, Haas, Haddad, Haddadin, Haffty, Haffty, Haffty, Haffty, Haffty, Hafty, Handa, Harari, Hasegawa, Haselow, Henk, Heyden, Heyden, Heyden, Heyden, Heyden, Heyden, Hitt, Holoye, Holoye, Homma, Hong, Hughes, Huguenin, Hussey, Jacobs, Jain, Jaulerry, Jeremic, Jeremic, Jeremic, Jeremic, Jeremic, Jones, Jortay, Kaneda, Kapstad, Kapstad, Katori, Keegan, Knowlton, Kotani, Kramer, Krishnamurthi, Kumar, Laccourreye, Lam, Laramore, Lavertu, Le, Le, Lee, Lewin, Licitra, Lim, Lippman, Lo, Lopes, Luboinski, Macfarlane, Magno, Maipang, Mantovani, Marechal, Martin, Martin, Martin, Mazeron, McGurk, Mechl, Merlano, Merlano, Merlano, Merlano, Merlano, Merlano, Mohr, Monson, Morita, Morton, Morton, Nervi, Nissenbaum, O'Connor, Olasz, Olasz, Oliver, Oliver, Olmi, Olmi, Paccagnella, Paccagnella, Panis, Papac, Parkin, Parmar, Partridge, Parvinen, Patel, Pavitt, Pearlman, Pentenero, Petrovich, Petrovich, Phillips, Pignon, Pinnaro, Pinto, Platzer, Posner, Price, Prévost, Racadot, Rao, Rao, Rapoport, Rasch, Rasch, Rentschler, Richard, Richard, Richard, Richard, Rischin, Rischin, Rischin, Rodrigo, Ruo Redda, Ryerson, Salvajoli, Sanchiz, Sanguineti, Schildhauer, Schildhauer, Schroder, Schuller, Schuller, Schuller, Sealy, Segura, Semrau, Shah, Shanta, Shaw, Shetty, Siodlak, Smid, Smid, Soo, Specenier, Staar, Staar, Stefani, Stefani, Stell, Stell, Sturgis, Suwinski, Szabo, Szpirglas, Szpirglas, Szpirglas, Taylor, Taylor, Taylor, Tejedor, Tepmongkol, Tobias, Tobias, Tobias, Tobias, Toohill, Toohill, Tsukuda, Tsukuda, Valverde, Vecchia, Vega, Vermund, Veronesi, Volling, Volling, Volling, Weissberg, Weissberg, Weissberg, Weissberg, Weissberg, Weissler, Wendt, Wendt, WHO, Woods, Woods, Woods, Woolgar, Yoshino, Yoshino, Zakotnik, Zakotnik, Zakotnik, Zorat, Zorat   +337 more
core   +6 more sources